ICICI Securities research report on Deepak Nitrite
Deepak Nitrite’s (DN) Q4FY25 underlying print suggests margin pressure intensified in Q4 with rise in supplies from China, particularly for agrochemical intermediates. However, it had early signs of recovery across segments with higher volumes and margin improvement. Yet, DN has refrained from providing any guidance for H1FY26; however, for FY26, it expects performance to normalise. It has taken measures to increase resilience of business by moving up in agrochemical value chain into technical partnerships with customers, and adding higher value products in agro and pharma intermediates. It has also added new products in personal care.
Outlook
Cut FY26/27 EPS by ~6% each; revise TP to INR 2,000 (from INR 2,120), valuing DN at 30x FY27E PE multiple (unchanged). Downgrade to HOLD (from Add).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
